Methylfenidaat Hcl Cf (Methylphenidate Hydrochloride)

Methylphenidate acts on the central nervous system to improve attention, reduce hyperactivity, and promote wakefulness in specific neurobehavioral disorders.

• Attention deficit hyperactivity disorder (ADHD): enhances concentration, reduces impulsivity and hyperactive behavior in children, adolescents, and adults.
• Narcolepsy: decreases excessive daytime sleepiness and improves daytime alertness.
• Adult ADHD: supports focus and reduces distractibility in adult patients with attention deficit hyperactivity disorder.

• Methylphenidate inhibits the reuptake of dopamine and norepinephrine by blocking their transporters (DAT and NET) in neuronal synapses. This increases the extracellular concentrations of these catecholamines, enhancing neurotransmission in brain regions that regulate attention, impulse control, and arousal, thereby producing its therapeutic effects in ADHD and narcolepsy. The heightened catecholaminergic activity modulates activity in the prefrontal cortex and basal ganglia, key circuits involved in executive function and sleep-wake regulation.

Methylphenidate may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Insomnia: difficulty falling or staying asleep.
• Decreased appetite: reduced hunger which may lead to weight loss.
• Headache: mild to moderate cranial pain.
• Stomach upset: nausea or abdominal discomfort.
• Irritability: mood swings and increased agitation.
• Weight loss: unintended reduction in body weight.

Serious or Rare Side Effects

• Cardiovascular events: chest pain, hypertension, or arrhythmias.
• Psychosis: hallucinations or delusional thinking.
• Severe allergic reaction: rash, swelling, or anaphylaxis.
• Priapism: prolonged painful erection.
• Seizures: convulsive episodes.
• Sudden death: rare fatal cardiac or cerebrovascular events.

Before prescribing methylphenidate, clinicians should consider several safety measures.

• Cardiovascular assessment: evaluate blood pressure and heart rate before initiating therapy.
• Psychiatric history review: monitor for emergence of psychosis, mania, or severe anxiety.
• Growth monitoring: track weight and height in pediatric patients regularly.
• Drug abuse potential: assess risk of misuse and schedule‑controlled substance regulations.
• Concomitant MAO inhibitor use: avoid co‑administration due to risk of hypertensive crisis.
• Store at ambient temperature below 25°C: keep in the original container, protect from moisture and light.

Methylphenidate can interact with several medications, requiring careful management.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): concurrent use can cause hypertensive crisis.
• Tricyclic antidepressants: may increase risk of cardiovascular side effects.
• Antihypertensive agents: methylphenidate can reduce their effectiveness, leading to elevated blood pressure.

Moderate Interactions (Monitor Closely)

• Selective serotonin reuptake inhibitors (SSRIs): may increase serotonin levels and risk of serotonin syndrome.
• Antacids (aluminum or magnesium): can affect absorption, requiring monitoring.
• Alcohol: may enhance central nervous system side effects such as dizziness.